Gene · 7114
Papers2,131
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,131
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Therapeutic Effect of Prolyl Endopeptidase Inhibitor in High-fat Diet-induced Metabolic Dysfunction-associated Fatty Liver Disease. | J Clin Transl Hepatol | 2023 | 37577240 | PubTator, text mining | PubMed |
| Artificial cells eavesdropping on HepG2 cells. | Interface Focus | 2023 | 37577001 | PubTator, text mining | PubMed |
| Polymeric biomaterials for wound healing. | Front Bioeng Biotechnol | 2023 | 37576995 | PubTator, text mining | PubMed |
| Dysregulated Signalling Pathways Driving Anticancer Drug Resistance. | Int J Mol Sci | 2023 | 37569598 | PubTator, text mining | PubMed |
| Proteomic and Metabolomic Analysis of Bone Marrow and Plasma from Patients with Extramedullary Multiple Myeloma Identifies Distinct Protein and Metabolite Signatures. | Cancers (Basel) | 2023 | 37568580 | PubTator, text mining | PubMed |
| Molecular mechanisms regulating natural menopause in the female ovary: a study based on transcriptomic data. | Front Endocrinol (Lausanne) | 2023 | 37564980 | PubTator, text mining | PubMed |
Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop. | Virchows Arch | 2023 | 37555980 | PubTator, text mining | PubMed |
| Thymosin β4 Alleviates Autoimmune Dacryoadenitis via Suppressing Th17 Cell Response. | Invest Ophthalmol Vis Sci | 2023 | 37531112 | PubTator, text mining | PubMed |
| Thymus-derived hormonal and cellular control of cancer. | Front Endocrinol (Lausanne) | 2023 | 37529610 | PubTator, text mining | PubMed |
| Detection and quantification of the metabolite Ac-Tβ1-14 in in vitro experiments and urine of rats treated with Ac-Tβ4: A potential biomarker of Ac-Tβ4 for doping tests. | Drug Test Anal | 2023 | 37515313 | PubTator, text mining | PubMed |
| Abnormal Expression of Prolyl Oligopeptidase (POP) and Its Catalytic Products Ac-SDKP Contributes to the Ovarian Fibrosis Change in Polycystic Ovary Syndrome (PCOS) Mice. | Biomedicines | 2023 | 37509566 | PubTator, text mining | PubMed |
| PreCanCell: An ensemble learning algorithm for predicting cancer and non-cancer cells from single-cell transcriptomes. | Comput Struct Biotechnol J | 2023 | 37501705 | PubTator, text mining | PubMed |
| Characterization of cytoskeletal and structural effects of INF2 variants causing glomerulopathy and neuropathy. | Sci Rep | 2023 | 37491439 | PubTator, text mining | PubMed |
| HBV-associated DLBCL of poor prognosis: advance in pathogenesis, immunity and therapy. | Front Immunol | 2023 | 37483605 | PubTator, text mining | PubMed |
| An Integrated Analysis Identified TAGLN2 As an Oncogene Indicator Related to Prognosis and Immunity in Pan-Cancer. | J Cancer | 2023 | 37476180 | PubTator, text mining | PubMed |
| The platelet transcriptome and proteome in Alzheimer's disease and aging: an exploratory cross-sectional study. | Front Mol Biosci | 2023 | 37457829 | PubTator, text mining | PubMed |
| Liquid biopsy: an examination of platelet RNA obtained from head and neck squamous cell carcinoma patients for predictive molecular tumor markers. | Explor Target Antitumor Ther | 2023 | 37455825 | PubTator, text mining | PubMed |
| Cardiovascular Functions of Ena/VASP Proteins: Past, Present and Beyond. | Cells | 2023 | 37443774 | PubTator, text mining | PubMed |
| Analysis of the genomic landscape of primary central nervous system lymphoma using whole-genome sequencing in Chinese patients. | Front Med | 2023 | 37418076 | PubTator, text mining | PubMed |
| Integrated analysis of DNA methylome and transcriptome reveals SFRP1 and LIPG as potential drivers of ovarian cancer metastasis. | J Gynecol Oncol | 2023 | 37417299 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7114/papers?page=9